Home > Healthcare > Medical Devices > Surgical Devices > heart closure devices market
Get a free sample of Heart Closure Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Heart Closure Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market is highly competitive, with key players including large multinationals like Abbott Laboratories, Boston Scientific Corporation, and Medtronic plc, which lead in innovation and extensive product portfolios. Regional companies and new entrants, particularly from APAC, are intensifying competition with affordable heart closure devices tailored for local markets. The market sees frequent technological advancements, such as advanced design, enhanced comfort, and precision and data tracking systems, which drive ongoing product development.
Prominent players operating in the heart closure devices industry include:
The global heart closure devices industry was valued at USD 4 billion in 2024 and is expected to grow at a CAGR of 15.9% from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases and the rising preference for minimally invasive procedures.
The North America heart closure devices market recorded USD 2.7 billion in revenue in 2024 and is anticipated to grow at a CAGR of 14.3% between 2025 and 2034, driven by the rising incidence of atrial septal defect (ASD) and patent foramen ovale (PFO).
The left atrial appendage (LAA) closure devices segment generated USD 2.2 billion in 2024, primarily due to their significant benefit in reducing stroke risk.
Key players in the industry include Abbott Laboratories, AtriCure, Biosense Webster, Boston Scientific Corporation, Cardia, Heartstitch, Lepu Medical Technology (Beijing) Co., Ltd., LifeTech Scientific Corporation, Medtronic, and Occlutech.